The Journal of Neuroscience, June 25, 2008, 28(26):6652-6658; doi:10.1523/JNEUROSCI.5530-07.2008
Previous Article | Next Article 
Neurobiology of Disease
Continuous
-Opioid Receptor Activation Reduces Neuronal Voltage-Gated Sodium Channel (NaV1.7) Levels through Activation of Protein Kinase C in Painful Diabetic Neuropathy
Munmun Chattopadhyay,1,2
Marina Mata,1,2 and
David J. Fink1,2
1Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109-0316, and 2VA Ann Arbor Healthcare System, Ann Arbor, Michigan 48105
Correspondence should be addressed to Dr. David J. Fink, 1914 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0316. Email: djfink{at}umich.edu
The NaV1.7 tetrodotoxin-sensitive voltage-gated sodium channel isoform plays a critical role in nociception. In rodent models of diabetic neuropathy, increased NaV1.7 in dorsal root ganglia (DRG) neurons correlates with the emergence of pain-related behaviors characteristic of painful diabetic neuropathy (PDN). We examined the effect of transgene-mediated expression of enkephalin on pain-related behaviors and their biochemical correlates in DRG neurons. Transfection of DRG neurons by subcutaneous inoculation of a herpes simplex virus-based vector expressing proenkephalin reversed nocisponsive behavioral responses to heat, cold, and mechanical pressure characteristic of PDN. Vector-mediated enkephalin production in vivo prevented the increase in DRG NaV1.7 observed in PDN, an effect that correlated with inhibition of phosphorylation of p38 MAPK (mitogen-activated protein kinase) and protein kinase C (PKC). Primary DRG neurons in vitro exposed to 45 mM glucose for 18 h also demonstrated an increase in NaV1.7 and increased phosphorylation of p38 and PKC; these changes were prevented by transfection in vitro with the enkephalin-expressing vector. The effect of hyperglycemia on NaV1.7 production in vitro was mimicked by exposure to PMA and blocked by the myristolated PKC inhibitor 20-28 or the p38 inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole]; the effect of vector-mediated enkephalin on NaV1.7 levels was prevented by naltrindole. The results of these studies suggest that activation of the presynaptic
-opioid receptor by enkephalin prevents the increase in neuronal NaV1.7 in DRG through inhibition of PKC and p38. These results establish a novel interaction between the
-opioid receptor and voltage-gated sodium channels.
Key words: pain; diabetic neuropathy; sodium channel; gene therapy; herpes simplex; enkephalins
Received July 4, 2007;
revised May 11, 2008;
accepted May 15, 2008.
Correspondence should be addressed to Dr. David J. Fink, 1914 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0316. Email: djfink{at}umich.edu